Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review
ABSTRACTThe primary objective of this paper is to serve as a valuable resource for policymakers who are confronted with the evolving landscape of the coronavirus disease 2019 (COVID-19), considering both free and cost-based vaccination approaches. The potential consequences of shifting from free to...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2313860 |
| _version_ | 1797305337876840448 |
|---|---|
| author | Li Ping Wong Hai Yen Lee Haridah Alias Gregory Zimet Tongyu Liu Yulan Lin Zhijian Hu |
| author_facet | Li Ping Wong Hai Yen Lee Haridah Alias Gregory Zimet Tongyu Liu Yulan Lin Zhijian Hu |
| author_sort | Li Ping Wong |
| collection | DOAJ |
| description | ABSTRACTThe primary objective of this paper is to serve as a valuable resource for policymakers who are confronted with the evolving landscape of the coronavirus disease 2019 (COVID-19), considering both free and cost-based vaccination approaches. The potential consequences of shifting from free to cost-based vaccination are explored, encompassing its impact on global vaccine equity and prioritization, economic well-being, healthcare systems and delivery, public health policies, and vaccine distribution strategies. Examining past studies on willingness to pay for the initial COVID-19 vaccine dose and booster shots provides insights into how individuals value COVID-19 vaccinations and underscores the significance of addressing issues related to affordability. If COVID-19 vaccinations incur expenses, using effective communication strategies that emphasize the importance of vaccination and personal health benefits can increase willingness to pay. Making COVID-19 vaccines accessible through public health programs or health insurance can help alleviate financial barriers and increase vaccination rates. |
| first_indexed | 2024-03-08T00:24:29Z |
| format | Article |
| id | doaj.art-05fed5c063a547f2a5614247b1742c42 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-08T00:24:29Z |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-05fed5c063a547f2a5614247b1742c422024-02-15T23:29:01ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2313860Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic reviewLi Ping Wong0Hai Yen Lee1Haridah Alias2Gregory Zimet3Tongyu Liu4Yulan Lin5Zhijian Hu6Department of Epidemiology and Health Statistics, Fujian Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, Fujian, ChinaTropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya, Kuala Lumpur, MalaysiaCentre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, MalaysiaDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USADepartment of Gynecology, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University, Fuzhou, Fujian, ChinaDepartment of Epidemiology and Health Statistics, Fujian Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, Fujian, ChinaDepartment of Epidemiology and Health Statistics, Fujian Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, Fujian, ChinaABSTRACTThe primary objective of this paper is to serve as a valuable resource for policymakers who are confronted with the evolving landscape of the coronavirus disease 2019 (COVID-19), considering both free and cost-based vaccination approaches. The potential consequences of shifting from free to cost-based vaccination are explored, encompassing its impact on global vaccine equity and prioritization, economic well-being, healthcare systems and delivery, public health policies, and vaccine distribution strategies. Examining past studies on willingness to pay for the initial COVID-19 vaccine dose and booster shots provides insights into how individuals value COVID-19 vaccinations and underscores the significance of addressing issues related to affordability. If COVID-19 vaccinations incur expenses, using effective communication strategies that emphasize the importance of vaccination and personal health benefits can increase willingness to pay. Making COVID-19 vaccines accessible through public health programs or health insurance can help alleviate financial barriers and increase vaccination rates.https://www.tandfonline.com/doi/10.1080/21645515.2024.2313860Cost-based vaccinationCOVID-19willingness to pay |
| spellingShingle | Li Ping Wong Hai Yen Lee Haridah Alias Gregory Zimet Tongyu Liu Yulan Lin Zhijian Hu Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review Human Vaccines & Immunotherapeutics Cost-based vaccination COVID-19 willingness to pay |
| title | Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review |
| title_full | Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review |
| title_fullStr | Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review |
| title_full_unstemmed | Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review |
| title_short | Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review |
| title_sort | cost based covid 19 vaccination and willingness to pay a post pandemic review |
| topic | Cost-based vaccination COVID-19 willingness to pay |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2313860 |
| work_keys_str_mv | AT lipingwong costbasedcovid19vaccinationandwillingnesstopayapostpandemicreview AT haiyenlee costbasedcovid19vaccinationandwillingnesstopayapostpandemicreview AT haridahalias costbasedcovid19vaccinationandwillingnesstopayapostpandemicreview AT gregoryzimet costbasedcovid19vaccinationandwillingnesstopayapostpandemicreview AT tongyuliu costbasedcovid19vaccinationandwillingnesstopayapostpandemicreview AT yulanlin costbasedcovid19vaccinationandwillingnesstopayapostpandemicreview AT zhijianhu costbasedcovid19vaccinationandwillingnesstopayapostpandemicreview |